1975International Journal of CancerRequires access

Inhibition of leukocyte migration in agarose by KC1 extracts of a human melanoma cell line grown in serum‐free medium

Arthur W. Boddie, Marshall M. Urist, Darwin O. Chee, E. Carmack Holmes, Donald L. Morton

Open publisher page 16 citations

Abstract

KCl extracts of Melanoma 14, a human melanoma cell line grown in chemically defined serum-free medium, inhibited leukocyte migration in 19/36 (53%) patients with malignant melanoma. Only 4/23 (17%) controls with non-melanoma malignancies and 4/25 (14%) normal subjects with no history of cancer were similarly inhibited. Only 2/27 melanoma patients tested against KCl extracts of normal muscle tissue excised from the donor of Melanoma 14 were significantly inhibited. Patients with Stage I (localized) melanoma and patients with Stage III (generalized) melanoma reacted with roughly equal frequency but the number of patients in each group was too small for meaningful statistical analysis. Leukocytes from the donor of Melanoma 14 were tested in a completely autologous system against extracts of Melanoma 14 tissue culture cells and extracts of autologous muscle and were specifically inhibited by the Melanoma 14 tissue culture extract (Migration Index = 0.67) but not by the extract of normal muscle (Migration Index = 0.96). Only 7/32 (22%) melanoma patients were significantly inhibited by an extract of non-melanoma tumor. These results suggest that melanoma-associated antigens are present in soluble extracts of this tumor line. Such extracts could provide a continuing source of standard melanoma-associated antigens for purification and chemical characterization and for diagnostic and prognostic tests in patients with malignant melanoma.

About this research paper

What this paper is about

KCl extracts of Melanoma 14, a human melanoma cell line grown in chemically defined serum-free medium, inhibited leukocyte migration in 19/36 (53%) patients with malignant melanoma. Only 4/23 (17%) controls with non-melanoma malignancies and 4/25 (14%) normal subjects with no history of cancer were similarly inhibited. Only 2/27 melanoma patients tested against KCl extracts of normal muscle tissue excised from the donor of Melanoma 14 were significantly inhibited. Patients with Stage I (localized) melanoma and patients with Stage III (generalized) melanoma reacted with roughly equal frequency but the number of patients in each group was too small for meaningful statistical analysis. Leukocytes from the donor of Melanoma 14 were tested in a completely autologous system against extracts of Melanoma 14 tissue culture cells and extracts of autologous muscle and were specifically inhibited by the Melanoma 14 tissue culture extract (Migration Index = 0.67) but not by the extract of normal muscle (Migration Index = 0.96). Only 7/32 (22%) melanoma patients were significantly inhibited by an extract of non-melanoma tumor. These results suggest that melanoma-associated antigens are present in soluble extracts of this tumor line. Such extracts could provide a continuing source of standard melanoma-associated antigens for purification and chemical characterization and for diagnostic and prognostic tests in patients with malignant melanoma.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

KCl extracts of Melanoma 14, a human melanoma cell line grown in chemically defined serum-free medium, inhibited leukocyte migration in 19/36 (53%) patients with malignant melanoma. Only 4/23 (17%) controls with non-melanoma malignancies and 4/25 (14%) normal subjects with no history of cancer were similarly inhibited. Only 2/27 melanoma patients tested against KCl extracts of normal muscle tissue excised from the donor of Melanoma 14 were significantly inhibited. Patients with Stage I (localized) melanoma and patients with Stage III (generalized) melanoma reacted with roughly equal frequency but the number of patients in each group was too small for meaningful statistical analysis. Leukocytes from the donor of Melanoma 14 were tested in a completely autologous system against extracts of Melanoma 14 tissue culture cells and extracts of autologous muscle and were specifically inhibited by the Melanoma 14 tissue culture extract (Migration Index = 0.67) but not by the extract of normal muscle (Migration Index = 0.96). Only 7/32 (22%) melanoma patients were significantly inhibited by an extract of non-melanoma tumor. These results suggest that melanoma-associated antigens are present in soluble extracts of this tumor line. Such extracts could provide a continuing source of standard melanoma-associated antigens for purification and chemical characterization and for diagnostic and prognostic tests in patients with malignant melanoma.

Key concepts: Melanoma, Medicine, Cell culture, Antigen, Cell, Cancer, Tissue culture, In vitro

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibition of leukocyte migration in agarose by KC1 extracts of a human melanoma cell line grown in serum‐free medium — Research Paper | ScholarLens